Localized recurrent prostate cancer after primary radiotherapy can be curatively treated using salvage iodine-125 ((125)I) brachytherapy. Selection is hampered by a lack of predictive factors for cancer control.
BERKELEY, CA (UroToday.com) - According to international recommendations, interstitial permanent brachytherapy with radioactive seeds is considered an established treatment option for low-risk prostate cancer.[1, 2]
Login to update email address, newsletter preferences and use bookmarks.